marty

THE price tag for John Travolta’s Saturday Night Fever suit is every bit as eye-watering as his dance moves.

The flared white three-piece outfit from the 1977 hit movie is expected to sell for as much as £300,000 at auction next month.

It is one of more than 1,400 items from film and TV that Propstore will be putting under the hammer in its four-day Summer Entertainment Memorabilia Auction.

The sale includes the fake axe wielded by Jack Nicholson in The Shining, a Harry ­Potter golden snitch and a hoverboard ridden by Michael J Fox in Back To The Future II.

A 15-inch stop-motion animation puppet from the 1949 film Mighty Joe Young is estimated to be worth up to £1.5million.

Here, we look at the most memorable mementoes up for grabs.

BANKS BIDS

Gordon Banks’ ‘Pele save’ shirt & 1966 medal set to fetch huge sums at auction

MEGA MEMORABILIA

Ringo Starr’s drum kit & Kurt Cobain’s guitar to sell for massive sum

May 8 (UPI) — President Donald Trump intends to fire Food and Drug Administration Commissioner Marty Makary because he is frustrated with the agency.

Trump signed off on the decision to replace Makary as he has clashed with Trump, officials in the Department of Health and Human Services and other officials in the administration, multiple reports said on Friday.

The reports — from NBC News, The New York Times, The Wall Street Journal and The Washington Post — all were attributed to Trump administration sources who requested anonymity because they were not authorized to comment on the issue.

Makary, a former surgeon at Johns Hopkins, was confirmed to run the FDA in March 2025 on a vote the included two Democratic members of the Senate voting yes.

His nomination carried some controversy because, like several other Trump cabinet members and nominees, is a former Fox News contributor who preferred that society develop natural immunity to the virus that causes COVID-19 instead of the CDC’s preferred method of using vaccine-induced immunity during the pandemic.

The reports suggest that Makary has struggled to run the FDA as long-time staff have left the agency and a range of healthcare, pharmaceutical and advocacy groups have been highly critical of its actions.

The Department of Health and Human Services and Makary have not commented on the reports, and sources for all four news organizations noted that the plan could change if Trump changes his mind.